Disclosed are methods of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related Compounds. The invention has a wide spectrum of important uses including hyperparathyroidism, Paget's disease, hypercalcemia of malignancy, osteolytic lesions produced by bone metastasis, bone loss due to immobilisation or sex hormone deficiency, osteomalacia, hyperostosis and osteopetrosis.

Web www.patentalert.com

< Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists

< Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders

> Glucagon-like peptide-1 analogs

> Methods and compositions for treating polycystic ovary syndrome

~ 00207